Cipher Pharmaceuticals Inc

Cipher (TSX:CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products directly in Canada and indirectly through partners in the U.S., and South America.

Cipher operates a lean corporate structure, employs strategic operational partnerships, out and in-licenses products, in addition to making selective investments in drug development to assemble a broad portfolio of prescription products.